发文分析
近年国家/地区发文量统计
| 国家/地区 | 数量 |
|---|---|
| USA | 95 |
| Italy | 78 |
| England | 39 |
| France | 27 |
| CHINA MAINLAND | 26 |
| Canada | 25 |
| GERMANY (FED REP GER) | 24 |
| Spain | 23 |
| Netherlands | 20 |
| Iran | 13 |
近年机构发文量统计
| 机构 | 数量 |
|---|---|
| ASSISTANCE PUBLIQUE HOPITAUX PARIS (APHP) | 14 |
| SORBONNE UNIVERSITE | 12 |
| TEHRAN UNIVERSITY OF MEDICAL SCIENCES | 11 |
| HARVARD UNIVERSITY | 9 |
| INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERC... | 9 |
| UNIVERSITY OF CALGARY | 9 |
| UNIVERSITY OF CALIFORNIA SYSTEM | 9 |
| UNIVERSITY OF FLORENCE | 9 |
| UNIVERSITY OF LONDON | 8 |
| FREE UNIVERSITY OF BERLIN | 7 |
近年文章引用他刊数据
| 文章名称 | 引用次数 |
|---|---|
| Tocilizumab for the treatment of chimeric antigen recept... | 61 |
| Statin-induced myalgia and myositis: an update on pathog... | 24 |
| Pathophysiology of systemic sclerosis: current understan... | 22 |
| The nocebo effect: a clinical challenge in the era of bi... | 19 |
| Pyoderma gangrenosum: a review of pathogenesis and treat... | 17 |
| Quality of life in psoriatic arthritis | 16 |
| Immunogenicity of biologic therapies: causes and consequ... | 14 |
| An update on generalized pustular psoriasis | 13 |
| Tofacitinib for the treatment of psoriasis and psoriatic... | 13 |
| Short- and long-term real-world effectiveness of omalizu... | 13 |
近年被他刊引用数据
| 期刊名称 | 引用次数 |
|---|---|
| FRONT IMMUNOL | 114 |
| EXPERT REV CLIN IMMU | 58 |
| SCI REP-UK | 37 |
| CLIN RHEUMATOL | 35 |
| INT J MOL SCI | 34 |
| ANN RHEUM DIS | 22 |
| AUTOIMMUN REV | 22 |
| CLIN EXP RHEUMATOL | 21 |
| INT J RHEUM DIS | 21 |
| CELLS-BASEL | 20 |